
- This event has passed.
Following recent publications from both ESMA and the FCA in relation to MiFID II, both manufacturers and distributors are now expected to be well underway with their preparations to meet the upcoming regulatory requirements.
Time is limited to have processes and procedures in place and opinion is still divided upon what the expectations and requirements actually are, although what is certainly clear is that investment firms manufacturing and distributing financial instruments must comply with product governance requirements. The European Working Group is close to finalising the MiFID II template (EMT), and the FCA are clear they will gold plate EU rules for non-MiFID firms by applying the provisions as guidance to UCITS and NURS managers.
Please join us for a view from Calastone of proposed approaches and requirements, as we understand them, featuring insight from a large asset management firms MiFID II project manager. This event will be of particular interest to individuals in firms who are responsible for addressing and meeting the Product Governance and Target Market requirements, both in terms of product and data, under MiFID II.